missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Clarinex™ Desloratidine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR16801G
Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Desloratadine is one of the orally active, highly selective peripheral H1 receptor antagonists that does not exert any significant effect on the central and autonomic nervous systems. The potency of desloratadine is more than that of loratadine and it exhibits substantial overall pharmacological profile. Featured Industries: Pharmaceutical (small molecule)Specifications
| 100643-71-8 | |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00871949 | |
| Certified Reference Material | |
| 310.82 |
| Clarinex | |
| C19H19 ClN2 | |
| Desloratadine; 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5 H- benzo[5,6 ]cyclohepta[1,2,b]pyridine; Clarinex(R); NSC 675447 | |
| 1 g | |
| Certified Reference Material |
Clarinex is a registered trademark of Schering Corp.